---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-015232"
form_type: "8-K"
ticker: "AMWL"
cik: "0001393584"
company_name: "American Well Corp"
filed_at: "2024-02-14T23:59:59+00:00"
generated_at: "2026-06-06T02:11:14.433975+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Amwell Q4 revenue $70.7M; net loss narrows to $50M; guides to 2026 EBITDA breakeven

## Summary
- Q4 2023 total revenue $70.7M (subscription $27.3M, AMG visits $32.1M); gross margin 34%.
- Q4 net loss $50.0M vs Q3 $137.1M (Q3 included $78.9M goodwill impairment); adjusted EBITDA -$36.9M.
- Full-year 2023 revenue $259M; net loss $679.2M (includes $436.5M goodwill impairment); adj. EBITDA -$165.4M.
- FY2024 guidance: revenue $259-269M, AMG visits 1.6-1.7M, adj. EBITDA -$160M to -$155M.
- Preliminary FY2025: revenue $335-350M, adj. EBITDA -$45M to -$35M; target adj. EBITDA breakeven by 2026.

## SEC filing metadata
- accession: 0000950170-24-015232
- form_type: 8-K
- ticker: AMWL
- cik: 0001393584
- company_name: American Well Corp
- filed_at: 2024-02-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1393584/000095017024015232/0000950170-24-015232-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1393584/000095017024015232/amwl-20240214.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-015232
- JSON: https://secwatch.observer/filing/0000950170-24-015232.json
- Plain text: https://secwatch.observer/filing/0000950170-24-015232.txt

## Key facts
- Earnings Releases
  American Well Corp reported fourth quarter and full year ended December 31, 2023 results: revenue Total Revenue of $70.7 million, net income Net loss was ($50.0) million.
  - Period: fourth quarter and full year ended December 31, 2023
  - Revenue: Total Revenue of $70.7 million
  - Net income: Net loss was ($50.0) million
  - Result: reported results
  source text: With the achievements of 2023, we begin 2024 with high conviction regarding our path to profitability.” Amwell Fourth Quarter 2023 Highlights: • Recorded Total Revenue of $70.7 million o Achieved subscription revenue of $27.3 million o Recorded Amwell Medical Group (“AMG”) visit revenue of $32.1 million • Reported gross margin of 34% • Net loss was ($50.0)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1393584/000095017024015232/0000950170-24-015232-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.